Project STARFISH - PRJ0002679

CompletedOBSERVATIONAL
Enrollment

1,909

Participants

Timeline

Start Date

February 20, 2023

Primary Completion Date

April 2, 2024

Study Completion Date

April 2, 2024

Conditions
SARS-CoV-2 InfectionInfluenza AInfluenza Type BRSV Infection
Interventions
DIAGNOSTIC_TEST

The Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel

A multiplex real-time PCR IVD test for the qualitative detection and identification of SARS-CoV-2, influenza A virus, influenza B virus, and respiratory syncytial virus (RSV).

Trial Locations (17)

21045

KUR Research at Columbia Medical Practice, Columbia

27103

Progressive Medicine of the Triad, Winston-Salem

27537

Mako Medical Laboratories, Henderson

32055

Multi-Specialty Research Associates, Lake City

33155

D&H National Research Centers, Miami

37421

ClinSearch, Chattanooga

38305

Helios Clinical Research, Jackson

46037

Quantigen, Fishers

48127

Vida Clinical Studies, Dearborn Heights

64110

MRI Global, Kansas City

76248

Helios Clinical Research, Keller

84096

Granger Medical Clinic, Riverton

89106

Clinical Research Center of Nevada, Las Vegas

92111

Women's Health Care Research, San Diego

92120

Medical Center for Clinical Research, San Diego

07642

KUR Research at AFC Urgent Care, Hillsdale

07652

KUR Research at AFC Urgent Care, Paramus

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NAMSA

OTHER

lead

Thermo Fisher Scientific, Inc

INDUSTRY